(Q42245958)

English

Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection

scientific article published on October 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Giuseppe Signoriello

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Evangelista Sagnelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mariantonietta Pisaturo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

A Marrone

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

M Starace

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

L E Adinolfi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

1 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

559-567

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Clinical and virological profiles in patients with multiple hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Influence of chronic coinfection with hepatitis B and C virus on liver histology.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Treatment of chronic hepatitis B: recommendations from an Italian workshop

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Efficacy of Pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

IL28B and the Control of Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1985-7

21 January 2018

Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/24081499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-013-1985-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24081499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42245958&oldid=2205160539"